Your browser doesn't support javascript.
loading
First noninvasive thermal ablation of a brain tumor with MR-guided focused ultrasound.
Coluccia, Daniel; Fandino, Javier; Schwyzer, Lucia; O'Gorman, Ruth; Remonda, Luca; Anon, Javier; Martin, Ernst; Werner, Beat.
Afiliação
  • Coluccia D; Department of Neurosurgery, Kantonsspital Aarau, Tellstrasse, 5001 Aarau, Switzerland ; Brain Tumor Center, Kantonsspital Aarau, 5001 Aarau, Switzerland.
  • Fandino J; Department of Neurosurgery, Kantonsspital Aarau, Tellstrasse, 5001 Aarau, Switzerland ; Brain Tumor Center, Kantonsspital Aarau, 5001 Aarau, Switzerland.
  • Schwyzer L; Department of Neurosurgery, Kantonsspital Aarau, Tellstrasse, 5001 Aarau, Switzerland ; Brain Tumor Center, Kantonsspital Aarau, 5001 Aarau, Switzerland.
  • O'Gorman R; Center for MR Research, University Children's Hospital, 8032 Zürich, Switzerland ; Children's Research Center, University Children's Hospital, 8032 Zürich, Switzerland.
  • Remonda L; Division of Neuroradiology, Department of Radiology, Kantonsspital Aarau, 5001 Aarau, Switzerland.
  • Anon J; Division of Neuroradiology, Department of Radiology, Kantonsspital Aarau, 5001 Aarau, Switzerland.
  • Martin E; Center for MR Research, University Children's Hospital, 8032 Zürich, Switzerland ; Children's Research Center, University Children's Hospital, 8032 Zürich, Switzerland.
  • Werner B; Center for MR Research, University Children's Hospital, 8032 Zürich, Switzerland ; Children's Research Center, University Children's Hospital, 8032 Zürich, Switzerland.
J Ther Ultrasound ; 2: 17, 2014.
Article em En | MEDLINE | ID: mdl-25671132
ABSTRACT
Magnetic resonance-guided focused ultrasound surgery (MRgFUS) allows for precise thermal ablation of target tissues. While this emerging modality is increasingly used for the treatment of various types of extracranial soft tissue tumors, it has only recently been acknowledged as a modality for noninvasive neurosurgery. MRgFUS has been particularly successful for functional neurosurgery, whereas its clinical application for tumor neurosurgery has been delayed for various technical and procedural reasons. Here, we report the case of a 63-year-old patient presenting with a centrally located recurrent glioblastoma who was included in our ongoing clinical phase I study aimed at evaluating the feasibility and safety of transcranial MRgFUS for brain tumor ablation. Applying 25 high-power sonications under MR imaging guidance, partial tumor ablation could be achieved without provoking neurological deficits or other adverse effects in the patient. This proves, for the first time, the feasibility of using transcranial MR-guided focused ultrasound to safely ablate substantial volumes of brain tumor tissue.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article